What's breaking now, across thousands of outlets.
While from a small study, the findings suggest PepGen’s therapy compares favorably to other RNA-based medicines in testing at Novartis and Dyne Therapeutics.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Cholera has killed more than 3,000 people worldwide since the start of the year, the World Health Organization said Tuesday, insisting its goal of cutting global cases by 90% by 2030 remained in…
Lady Gaga's Born This Way Foundation, collaborating with Jack dot org, has introduced the Be There Certificate programme.
Frontotemporal dementia often results in early changes in personality or behavior before changes in cognitive skills. People with this condition who have lower levels of conscientiousness, a…
(MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity…
(MedPage Today) -- Testosterone use among females has risen since 2016 and is frequently prescribed without a documented diagnosis of hypoactive sexual desire disorder, the sole evidence-based…
(MedPage Today) -- A single-use bioengineered liver paired with an extracorporeal blood circuit that replicates key functions of a human liver was shown to be safe among patients with syndromes of…
